GordanaVlahovicMD

Oncology • Durham, NC

Assistant Professor, Medicine, Duke University School of Medicine

Join to view full profile

Dr. Vlahovic is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Vlahovic's full profile

Already have an account?

Office
20 Duke Medicine Circle
Durham, NC 27710
Phone+1 919-684-5301
Is this information wrong?

Education & Training

Duke University HospitalFellowship, Hematology and Medical Oncology, 2000 - 2003
Duke University HospitalResidency, Internal Medicine, 1997 - 2000
University of Zagreb Faculty of MedicineClass of 1987

Certifications & Licensure

NC State Medical License 2001 - 2022

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Study Using a Genomic Predictor of Platinum Resistance to Guide Therapy in Stage IIIB/IV Non-Small Cell Lung Cancer Start of enrollment: 2007 May 01
Terminated
Phase 2
Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia Start of enrollment: 2007 Apr 24
Completed
Phase 1
Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2006 Feb 06
Completed
Phase 1
Vaccine Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Start of enrollment: 2007 Sep 01
Completed
Phase 2
Evaluation of Recovery From Drug-Induced Lymphopenia Using Cytomegalovirus-specific T-cell Adoptive Transfer Start of enrollment: 2008 Sep 01
Completed
Phase 1
Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme Start of enrollment: 2009 Sep 01
Completed
Phase 1
Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Glioblastoma Start of enrollment: 2014 Jan 09
Terminated
Phase 1, Phase 2
A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients Start of enrollment: 2014 Feb 07
Active, not recruiting
Phase 3
Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571 Start of enrollment: 2004 Nov 01
Terminated
Phase 1, Phase 2
IDH1 Peptide Vaccine for Recurrent Grade II Glioma Start of enrollment: 2016 Jan 28
Completed
Phase 1
A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma Start of enrollment: 2015 Jan 01
Completed
Phase 1, Phase 2
EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma Start of enrollment: 2017 Feb 01
Terminated
Phase 1
PVSRIPO in Recurrent Malignant Glioma Start of enrollment: 2017 Jun 01
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

370 citations
Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma: A Phase 2 Randomized Clinical Trial.
Eileen M. O'Reilly, Do Youn Oh, Neesha C. Dhani, Daniel J. Renouf, Myung Ah Lee, Weijing Sun, George A. Fisher, Aram F. Hezel, Shao Chun Chang, Gordana Vlahovic, Osamu...> ;JAMA Oncology. 2019 Oct 1
18 citations
Tolerability and efficacy of durvalumab in Japanese patients with advanced solid tumors.
Yutaka Fujiwara, Haruo Iguchi, Noboru Yamamoto, Manabu Hayama, Masahiro Nii, Shinya Ueda, Keiko Komuro, Mariko Sugimoto, Gordana Vlahovic, Toshiyuki Kozuki> ;Cancer Science. 2019 May 1
15 citations
A Phase I Trial of the IGF‐1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer
Gordana Vlahovic, Kellen L. Meadows, Ace J. Hatch, Jingquan Jia, Andrew B. Nixon, Hope E. Uronis, Michael A. Morse, M. Angelica Selim, Jeffrey Crawford, Richard F. Rie...> ;The Oncologist. 2018 Jul 1
455 citations
Recurrent glioblastoma treated with recombinant poliovirus
Annick Desjardins, Matthias Gromeier, James E. Herndon, Nike Beaubier, Dani P. Bolognesi, Allan H. Friedman, Henry S. Friedman, Frances McSherry, Andrea Muscat, Smita ...> ;The New England Journal of Medicine. 2018 Jun 26
22 citations
Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma
Mary Lou Affronti, Jennifer G. Jackman, Frances McSherry, James E. Herndon, Elwood C. Massey, Eric S. Lipp, Annick Desjardins, Henry S. Friedman, Gordana Vlahovic, Jam...> ;The Oncologist. 2018 Aug 1
308 citations
Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
Antonio Omuro, Gordana Vlahovic, Michael Lim, Solmaz Sahebjam, Joachim M. Baehring, Timothy F. Cloughesy, Alfredo Voloschin, Shakti Ramkissoon, Keith L. Ligon, Robert ...> ;Neuro-Oncology. 2018 Apr 9
70 citations
Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.
Elizabeth A. Reap, Carter M. Suryadevara, Kristen A. Batich, Luis Sanchez-Perez, Gary E. Archer, Robert J. Schmittling, Pamela Norberg, James E. Herndon, Patrick Healy...> ;Cancer Research. 2018 Jan 1
18 citations
A cross sectional analysis from a single institution’s experience of psychosocial distress and health-related quality of life in the primary brain tumor population
Dina Randazzo, Frances McSherry, James E. Herndon, Mary Lou Affronti, Eric S. Lipp, Charlene Flahiff, Elizabeth Miller, Sarah Woodring, Maria Freeman, Patrick Healy, J...> ;Journal of Neuro-Oncology. 2017 Jul 1
181 citations
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination
Kristen A. Batich, Elizabeth A. Reap, Gary E. Archer, Luis Sanchez-Perez, Smita K. Nair, Robert J. Schmittling, Pam Norberg, Weihua Xie, James E. Herndon, Patrick Heal...> ;Clinical Cancer Research. 2017 Apr 15
62 citations
Immunotherapy approaches in the treatment of malignant brain tumors
Anastasie Dunn-Pirio, Gordana Vlahovic> ;Cancer. 2017 Mar 1
11 citations
A Phase I, First-in-Human Study of AMG 780, an Angiopoietin-1 and -2 Inhibitor, in Patients with Advanced Solid Tumors
Afshin Dowlati, Gordana Vlahovic, Ronald B. Natale, Erik Rasmussen, Indrajeet Singh, Yuying C. Hwang, John M. Rossi, Michael Bass, Gregory Friberg, Cheryl A. Pickett> ;Clinical Cancer Research. 2016 Sep 15
29 citations
Embracing rejection: Immunologic trends in brain metastasis.
S. Harrison Farber, Vadim Tsvankin, Jessica L. Narloch, Grace Kim, April K.S. Salama, Gordana Vlahovic, Kimberly L. Blackwell, John P. Kirkpatrick, Peter E. Fecci> ;Oncoimmunology. 2016 Apr 11
12 citations
Vaccine Therapy, Oncolytic Viruses, and Gliomas.
Annick Desjardins, Gordana Vlahovic, Henry S. Friedman> ;Oncology. 2016 Mar 16
1 citations
Detecting somatic mutations in genomic sequences by means of Kolmogorov-Arnold analysis.
V G Gurzadyan, H Yan, G Vlahovic, A Kashin, P Killela, Z Reitman, S Sargsyan, G Yegorian, G Milledge, B Vlahovic> ;Royal Society Open Science. 2015 Aug 1
19 citations
Programmed death ligand 1 (PD-L1) as an immunotherapy target in patients with glioblastoma.
Gordana Vlahovic, Peter E. Fecci, David A. Reardon, John H. Sampson> ;Neuro-Oncology. 2015 Aug 1
35 citations
Phase 1 study of ixazomib, an investigational proteasome inhibitor, in advanced non-hematologic malignancies
David Smith, Thea Kalebic, Jeffrey R. Infante, Lillian L. Siu, Daniel C. Sullivan, Gordana Vlahovic, John S. Kauh, Feng Gao, Allison Berger, Stephen Tirrell, Neeraj Gu...> ;Investigational New Drugs. 2015 Mar 18
41 citations
A phase I safety and pharmacokinetic study of ABT-263 in combination with carboplatin/paclitaxel in the treatment of patients with solid tumors
Gordana Vlahovic, Vassiliki Karantza, Ding Wang, David Cosgrove, Nikita Rudersdorf, Jianning Yang, Hao Xiong, Todd Busman, Mack Mabry> ;Investigational New Drugs. 2014 Jun 5
2 citations
Editorial on “Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccination for Recurrent Glioblastoma: A Phase II, Single Arm Trial”
John H. Sampson, Gordana Vlahovic> ;Neuro-Oncology. 2014 Feb 1
15 citations
PET with 62Cu-ATSM and 62Cu-PTSM is a useful imaging tool for hypoxia and perfusion in pulmonary lesions.
Tian Zhang, Shiva K. Das, Diane R. Fels, Katherine S. Hansen, Terence Z. Wong, Mark W. Dewhirst, Gordana Vlahovic> ;AJR. American Journal of Roentgenology. 2013 Oct 22
31 citations
A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors
Gordana Vlahovic, Kellen L. Meadows, Hope E. Uronis, Michael A. Morse, Gerard C. Blobe, Richard F. Riedel, S. Yousuf Zafar, A. Alvarez-Secord, Jon P. Gockerman, Alexan...> ;Cancer Chemotherapy and Pharmacology. 2012 May 26
133 citations
Cancer- and Chemotherapy- Induced Anemia Clinical Practice Guidelines in Oncology
George M. Rodgers, Pamela S. Becker, Morey A. Blinder, David Cella, Asher A. Chanan-Khan, Charles S. Cleeland, Peter F. Coccia, Benjamin Djulbegovic, Jeffrey A. Gilrea...> ;Journal of the National Comprehensive Cancer Network. 2012 May 1
Retraction: Characterizing the Clinical Relevance of an Embryonic Stem Cell Phenotype in Lung Adenocarcinoma
Marvaretta Stevenson, William Mostertz, Chaitanya R. Acharya, William Kim, Kelli S. Walters, William T. Barry, Kristin Higgins, Sascha A. Tuchman, Jeffrey Crawford, Go...> ;Clinical Cancer Research. 2012 Mar 15
3 citations
Lower incidence of deletions in the survival of motor neuron gene and the neuronal apoptosis inhibitory protein gene in children with spinal muscular atrophy from Serbia.
Marijana Miskovic, Tanja Lalic, Danijela Radivojevic, Sanja Cirkovic, Gordana Vlahovic, D. Zamurovic, Marija Guc-Scekic> ;The Tohoku Journal of Experimental Medicine. 2011 Nov 1
328 citations
Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double...
Roy S. Herbst, Rafat Ansari, Frederique Bustin, Patrick J. Flynn, Lowell L. Hart, Gregory A. Otterson, Gordana Vlahovic, Chang-Heok Soh, Paula O'Connor, John D. Hainsw...> ;Lancet. 2011 May 28
14 citations
MHC class I-presented lung cancer-associated tumor antigens identified by immunoproteomics analysis are targets for cancer-specific T cell response.
Vivekananda Shetty, Gomathinayagam Sinnathamby, Zacharie Nickens, Punit Shah, Julie Hafner, Lisa Mariello, Shivali Kamal, Gordana Vlahovic, H. Kim Lyerly, Michael A. M...> ;Journal of Proteomics. 2011 May 1
Join now to see all